The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: amphotericin b     Quarter: 2016Q3

Total Records: 123     Number of Pages: 7

DRUGNAME PT EventCount
Amphotericin B, Liposome Hepatic function abnormal 2
AMPHOTERICIN B, LIPOSOME Hyponatraemia 2
AMPHOTERICIN B, LIPOSOME Meningitis cryptococcal 2
AMPHOTERICIN B, LIPOSOME Pneumocystis jirovecii pneumonia 2
AMPHOTERICIN B, LIPOSOME Pneumonia klebsiella 2
AMPHOTERICIN B, LIPOSOME Rash macular 2
Amphotericin B, Liposome Treatment failure 2
AMPHOTERICIN B. Acinetobacter bacteraemia 2
AMPHOTERICIN B. Acute graft versus host disease in intestine 2
AMPHOTERICIN B. Acute graft versus host disease in skin 2
AMPHOTERICIN B. Acute kidney injury 2
AMPHOTERICIN B. Adverse event 2
AMPHOTERICIN B. Exposure during pregnancy 2
AMPHOTERICIN B. Immune reconstitution inflammatory syndrome 2
AMPHOTERICIN B. Liver disorder 2
AMPHOTERICIN B. Nausea 2
AMPHOTERICIN B. Renal impairment 2
AMPHOTERICIN B. Sinusitis bacterial 2
AMPHOTERICIN B. Ulcerative keratitis 2
amphotericin B (+) cholesterol (+) distearoylphosphatidylglycerol (+) Drug ineffective 1

Total Records: 123     Number of Pages: 7